Creo Medical Group PLC Cash Flow Conversion Efficiency

Latest as of December 2025: -0.684x

Creo Medical Group PLC cash flow conversion efficiency. Based on the latest financial reports, Creo Medical Group PLC (CREO) has a cash flow conversion efficiency ratio of -0.684x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-34.20 Million ≈ $-4.16K USD) by net assets (GBX50.00 Million ≈ $6.08K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Creo Medical Group PLC (2014–2025)

Cash flow conversion efficiency of Creo Medical Group PLC from 2014 to 2025. This chart illustrates how Creo Medical Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CREO share price today for real-time trading data and today's change.

Creo Medical Group PLC Cash Flow Conversion Ratio Explained

Creo Medical Group PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Creo Medical Group PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Creo Medical Group PLC ranked by their cash flow conversion efficiency. Also see market value of Creo Medical Group PLC for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Prostatype Genomics AB ST:PROGEN	-0.234x
Oriental Rise Holdings Limited Ordinary Shares NASDAQ:ORIS	0.012x
Arcandor AG DU:ARO	N/A
Kovo Healthtech Corp V:KOVO	0.032x
Newtopia Inc V:NEWU	0.060x
ODINWELL AB F:0AF	N/A
Cora Gold Limited LSE:CORA	-0.013x
COPPERCORP RESOURCES INC. F:NU0	-0.636x

Annual Cash Flow Conversion Efficiency for Creo Medical Group PLC (2014–2025)

The table below shows the annual cash flow conversion efficiency of Creo Medical Group PLC from 2014 to 2025. Review Creo Medical Group PLC (CREO) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX50.00 Million ≈ $6.08K	GBX-18.60 Million ≈ $-2.26K	-0.372x	+28.95%
2024-12-31	GBX42.40 Million ≈ $5.16K	GBX-22.20 Million ≈ $-2.70K	-0.524x	-44.96%
2023-12-31	GBX59.80 Million ≈ $7.28K	GBX-21.60 Million ≈ $-2.63K	-0.361x	+28.59%
2022-12-31	GBX49.40 Million ≈ $6.01K	GBX-24.99 Million ≈ $-3.04K	-0.506x	-42.74%
2021-12-31	GBX73.32 Million ≈ $8.92K	GBX-25.98 Million ≈ $-3.16K	-0.354x	-38.36%
2020-12-31	GBX62.81 Million ≈ $7.64K	GBX-16.09 Million ≈ $-1.96K	-0.256x	-83.44%
2019-12-31	GBX82.66 Million ≈ $10.06K	GBX-11.54 Million ≈ $-1.40K	-0.140x	+53.07%
2018-12-31	GBX47.71 Million ≈ $5.81K	GBX-14.20 Million ≈ $-1.73K	-0.298x	+68.83%
2018-06-30	GBX7.33 Million ≈ $891.73	GBX-7.00 Million ≈ $-851.17	-0.955x	-102.27%
2017-06-30	GBX14.65 Million ≈ $1.78K	GBX-6.91 Million ≈ $-841.33	-0.472x	+53.13%
2016-06-30	GBX1.63 Million ≈ $198.22	GBX-1.64 Million ≈ $-199.58	-1.007x	-3.79%
2016-02-29	GBX3.22 Million ≈ $392.03	GBX-3.13 Million ≈ $-380.30	-0.970x	+68.09%
2015-02-28	GBX748.41K ≈ $91.06	GBX-2.27 Million ≈ $-276.80	-3.040x	-206.94%
2014-02-28	GBX1.37 Million ≈ $167.26	GBX-1.36 Million ≈ $-165.64	-0.990x	--

About Creo Medical Group PLC

LSE:CREO UK Medical Devices

Market Cap

$628.03K

GBX5.16 Billion GBX

Market Cap Rank

#30937 Global

#878 in UK

Share Price

GBX10.63

Change (1 day)

-2.30%

52-Week Range

GBX9.65 - GBX17.75

All Time High

GBX243.00